London, UK (February 21-22, 2006)
Polymorphism & crystallisation is a critically important area for pharma companies' with the potential to lose millions if they don't get it right. Pharma IQ's London Polymorphism & Crystallisation Forum is now in it's 3rd year and is the largest, most established dedicated meeting globally. The 2006 event will again be focusing on scientific, technical and IP issues, bringing delegates recent case studies and up-to-the minute research from leading figured including Joel Bernstein. It will provide insight into recent patent litigation, identification and characterisation techniques, amorphous materials, strategies to control polymorphism, and in addition it will feature a unique focus day looking at the development and use of pharmaceutical co-crystals.
More: http://www.iqpc-pharma.com/cgi-bin/templates/document.html?topic=237&e
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology projects - Plant biotechnology, Animal biotechnology, environmetal, ..
Bioenergy 2007 - Conference bioenergy 2007
More than 30 new species of bacteria discovered in patient samples
Gene-edited pig kidney transplanted into first living human patient